TTY Biopharm Company Limited (TPEX: 4105)
Taiwan
· Delayed Price · Currency is TWD 72.70
0.00 (0.00%)
Dec 20, 2024, 1:30 PM CST
TTY Biopharm Company Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 18,077 | 19,991 | 20,737 | 17,107 | 17,057 | 20,489 | Upgrade
|
| Market Cap Growth | -4.79% | -3.60% | 21.22% | 0.29% | -16.75% | 7.71% | Upgrade
|
| Enterprise Value | 18,267 | 20,061 | 20,686 | 16,707 | 17,498 | 20,328 | Upgrade
|
| Last Close Price | 72.70 | 76.95 | 76.41 | 60.43 | 57.22 | 65.31 | Upgrade
|
| PE Ratio | 16.19 | 17.71 | 18.95 | 20.56 | 18.46 | 22.76 | Upgrade
|
| Forward PE | 16.16 | 14.81 | 17.45 | 16.54 | 13.10 | 17.10 | Upgrade
|
| PS Ratio | 3.10 | 3.63 | 4.10 | 3.77 | 4.04 | 4.59 | Upgrade
|
| PB Ratio | 2.91 | 3.07 | 3.33 | 2.97 | 2.81 | 3.32 | Upgrade
|
| P/TBV Ratio | 3.14 | 3.46 | 3.83 | 3.39 | 3.21 | 3.77 | Upgrade
|
| P/FCF Ratio | 17.54 | 19.85 | 18.12 | 14.30 | 47.61 | 17.97 | Upgrade
|
| P/OCF Ratio | 16.29 | 18.42 | 16.78 | 13.62 | 32.41 | 16.93 | Upgrade
|
| EV/Sales Ratio | 3.14 | 3.64 | 4.09 | 3.68 | 4.14 | 4.55 | Upgrade
|
| EV/EBITDA Ratio | 10.88 | 12.81 | 14.69 | 12.82 | 15.75 | 14.76 | Upgrade
|
| EV/EBIT Ratio | 12.24 | 14.62 | 16.85 | 14.65 | 18.28 | 16.55 | Upgrade
|
| EV/FCF Ratio | 17.72 | 19.92 | 18.08 | 13.97 | 48.84 | 17.83 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.29 | 0.29 | 0.37 | 0.35 | 0.31 | Upgrade
|
| Debt / EBITDA Ratio | 1.52 | 1.19 | 1.28 | 1.65 | 1.93 | 1.40 | Upgrade
|
| Debt / FCF Ratio | 2.24 | 1.85 | 1.58 | 1.79 | 5.98 | 1.70 | Upgrade
|
| Asset Turnover | 0.57 | 0.57 | 0.54 | 0.49 | 0.45 | 0.48 | Upgrade
|
| Inventory Turnover | 1.74 | 2.08 | 2.05 | 1.71 | 1.64 | 1.94 | Upgrade
|
| Quick Ratio | 1.30 | 1.62 | 1.35 | 1.23 | 1.42 | 1.33 | Upgrade
|
| Current Ratio | 1.77 | 2.08 | 1.73 | 1.56 | 1.88 | 1.64 | Upgrade
|
| Return on Equity (ROE) | 17.29% | 17.56% | 18.38% | 13.89% | 15.98% | 14.45% | Upgrade
|
| Return on Assets (ROA) | 8.08% | 8.81% | 8.12% | 7.64% | 6.33% | 8.25% | Upgrade
|
| Return on Capital (ROIC) | 9.31% | 10.46% | 9.62% | 8.84% | 7.33% | 9.60% | Upgrade
|
| Earnings Yield | 6.18% | 5.64% | 5.28% | 4.86% | 5.42% | 4.39% | Upgrade
|
| FCF Yield | 5.70% | 5.04% | 5.52% | 6.99% | 2.10% | 5.56% | Upgrade
|
| Dividend Yield | 4.81% | 4.55% | 4.45% | 4.96% | 6.99% | 6.12% | Upgrade
|
| Payout Ratio | 77.23% | 74.91% | 68.16% | 119.56% | 107.62% | 124.31% | Upgrade
|
| Buyback Yield / Dilution | -0.05% | -0.03% | 0.02% | 0.00% | -0.03% | 0.01% | Upgrade
|
| Total Shareholder Return | 4.76% | 4.52% | 4.47% | 4.97% | 6.96% | 6.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.